Elsulfavirine
- Generic Name
- Elsulfavirine
- Drug Type
- Small Molecule
- Chemical Formula
- C24H17BrCl2FN3O5S
- CAS Number
- 868046-19-9
- Unique Ingredient Identifier
- ZC4CGO0RUG
- Background
Elsulfavirine is under investigation in clinical trial NCT03706898 (Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs).
Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Viriom
- Target Recruit Count
- 24
- Registration Number
- NCT05165550
- Locations
- 🇺🇸
Altasciences Clinical Los Angeles, Inc., Los Angeles, California, United States
An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- Viriom
- Target Recruit Count
- 15
- Registration Number
- NCT05148754
- Locations
- 🇷🇺
State Budgetary Institution Healthcare of the City of Moscow " V. P. Demikhov City Clinical Hospital of the Department of Healthcare of the City of Moscow", Moscow, Russian Federation
Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500
- Conditions
- HIV-infection
- Interventions
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2018-10-04
- Lead Sponsor
- Viriom
- Target Recruit Count
- 24
- Registration Number
- NCT02489487
- Locations
- 🇹🇭
Faculty of Medicine, Siriraj Hospital, Bangkok, Wanglang Road, Thailand
Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy
- Conditions
- HIV-1-infection
- Interventions
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2018-09-25
- Lead Sponsor
- Viriom
- Target Recruit Count
- 150
- Registration Number
- NCT02489461
- Locations
- 🇷🇺
Moscow Prevention AIDS Center, Moscow, Russian Federation
🇷🇺Lipetsk regional center for AIDS prevention, Lipetsk, Lipetsk Region, Russian Federation
🇷🇺Perm Regional center for AIDS prevention, Perm, Perm Region, Russian Federation
Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2015-07-03
- Lead Sponsor
- Viriom
- Target Recruit Count
- 36
- Registration Number
- NCT02489435
- Locations
- 🇷🇺
Central Clinical City Hospital, Reutov, Moscow region, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.